These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 3909806

  • 1. A phase II study of spirogermanium in advanced human malignancy.
    Vogelzang NJ, Gesme DH, Kennedy BJ.
    Am J Clin Oncol; 1985 Aug; 8(4):341-4. PubMed ID: 3909806
    [Abstract] [Full Text] [Related]

  • 2. Phase I study of spirogermanium given daily.
    Legha SS, Ajani JA, Bodey GP.
    J Clin Oncol; 1983 May; 1(5):331-6. PubMed ID: 6668504
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase I clinical trial of spirogermanium.
    Schein PS, Slavik M, Smythe T, Hoth D, Smith F, Macdonald JS, Woolley PV.
    Cancer Treat Rep; 1980 May; 64(10-11):1051-6. PubMed ID: 7459890
    [Abstract] [Full Text] [Related]

  • 7. Phase II study of spirogermanium in patients with advanced carcinoma of the cervix.
    Brenner DE, Rosenshein NB, Dillon M, Jones HW, Forastiere A, Tipping S, Burnett LS, Greco FA, Wiernik PH.
    Cancer Treat Rep; 1985 Apr; 69(4):457-8. PubMed ID: 3995514
    [No Abstract] [Full Text] [Related]

  • 8. [Metastatic cancer of the prostate: phase II study of spirogermanium (NSC 192965)].
    Bui NB, Chauvergne J, Brunet R, Richaud P, Hoerni B, Lagarde C, Le Guillou M.
    Bull Cancer; 1986 Apr; 73(1):65-7. PubMed ID: 3779124
    [Abstract] [Full Text] [Related]

  • 9. Phase II study of spirogermanium in the treatment of metastatic breast cancer.
    Pinnamaneni K, Yap HY, Legha SS, Blumenschein GR, Bodey GP.
    Cancer Treat Rep; 1984 Sep; 68(9):1197-8. PubMed ID: 6478457
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase II trial of spirogermanium for treatment of advanced breast cancer.
    Falkson G, Falkson HC.
    Cancer Treat Rep; 1983 Feb; 67(2):189-90. PubMed ID: 6825129
    [No Abstract] [Full Text] [Related]

  • 13. A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study.
    Eisenhauer E, Quirt I, Connors JM, Maroun J, Skillings J.
    Invest New Drugs; 1985 Feb; 3(3):307-10. PubMed ID: 4066225
    [Abstract] [Full Text] [Related]

  • 14. Therapy for advanced renal cell cancer with spirogermanium: a Southwest Oncology Group Study.
    Saiers JH, Slavik M, Stephens RL, Crawford ED.
    Cancer Treat Rep; 1987 Feb; 71(2):207-8. PubMed ID: 3802117
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II trial of spirogermanium in breast adenocarcinoma: a Cancer and Leukemia Group B Study.
    Budman DR, Ginsberg S, Perry M, Weinberg V, Schein P, Hanson J, Coleman M, Wood W.
    Cancer Treat Rep; 1982 Aug; 66(8):1667-8. PubMed ID: 7105058
    [No Abstract] [Full Text] [Related]

  • 17. Phase II Eastern Cooperative Oncology Group Study of spirogermanium in previously treated lymphoma.
    Boros L, Tsiatis AA, Neiman RS, Mann RB, Glick JH.
    Cancer Treat Rep; 1986 Jul; 70(7):917-8. PubMed ID: 3719586
    [No Abstract] [Full Text] [Related]

  • 18. Phase II study of spirogermanium in advanced ovarian malignancy.
    Tropé C, Mattsson W, Gynning I, Johnsson JE, Sigurdsson K, Orbert B.
    Cancer Treat Rep; 1981 Jul; 65(1-2):119-20. PubMed ID: 6261944
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.